Anya Biopharm Inc. (TPEX:7776)

Market Cap	1.90B +2.0%
Revenue (ttm)	24.83M +1,369.5%
Net Income	-75.19M
EPS	-1.53
Shares Out	49.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,011
Average Volume	51,859
Open	38.90
Previous Close	38.35
Day's Range	37.05 - 38.90
52-Week Range	19.05 - 70.60
Beta	n/a
RSI	39.02
Earnings Date	Nov 7, 2025

About Anya Biopharm

Anya Biopharm Inc., a pharmaceutical company, develops platforms for the delivery of oral peptides in Taiwan, rest of Asia, and Europe. The company is also developing ANY002 and ANY004, oral GLP1 products; ANY003, a tnfα inhibitor; and ANY00x. In addition, it engages in the research, development, and testing business. Anya Biopharm Inc. was founded in 2016 and is based in Taipei, Taiwan.

• Industry: Pharmaceutical Preparations
• Founded: 2016
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7776

Financial Performance

In 2024, Anya Biopharm's revenue was 21.60 million, an increase of 831.26% compared to the previous year's 2.32 million. Losses were -36.96 million, 31.6% more than in 2023.